FI961380A - Kompositioner för hindrande och behandling av tumörer förorsakade av virus - Google Patents

Kompositioner för hindrande och behandling av tumörer förorsakade av virus Download PDF

Info

Publication number
FI961380A
FI961380A FI961380A FI961380A FI961380A FI 961380 A FI961380 A FI 961380A FI 961380 A FI961380 A FI 961380A FI 961380 A FI961380 A FI 961380A FI 961380 A FI961380 A FI 961380A
Authority
FI
Finland
Prior art keywords
prevention
compositions
treatment
viral tumors
tumors
Prior art date
Application number
FI961380A
Other languages
English (en)
Finnish (fi)
Other versions
FI961380A0 (sv
Inventor
Ernest W Boyer
Robert L Charles
Original Assignee
Solvay Enzymes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Enzymes Inc filed Critical Solvay Enzymes Inc
Publication of FI961380A0 publication Critical patent/FI961380A0/sv
Publication of FI961380A publication Critical patent/FI961380A/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/917Aspergillus niger

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI961380A 1993-09-27 1996-03-26 Kompositioner för hindrande och behandling av tumörer förorsakade av virus FI961380A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/126,660 US5500359A (en) 1993-09-27 1993-09-27 Method for producing a therapeautic composition for papillomavirus-induced tumors with aspergillus niger
PCT/IB1994/000303 WO1995008998A1 (en) 1993-09-27 1994-09-16 Compositions for the prevention and treatment of viral-induced tumors

Publications (2)

Publication Number Publication Date
FI961380A0 FI961380A0 (sv) 1996-03-26
FI961380A true FI961380A (sv) 1996-03-26

Family

ID=22426064

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961380A FI961380A (sv) 1993-09-27 1996-03-26 Kompositioner för hindrande och behandling av tumörer förorsakade av virus

Country Status (11)

Country Link
US (4) US5500359A (sv)
EP (1) EP0725646A1 (sv)
JP (1) JPH09503206A (sv)
KR (1) KR960704561A (sv)
CN (1) CN1087941C (sv)
AU (1) AU699133B2 (sv)
BR (1) BR9407660A (sv)
CA (1) CA2172261A1 (sv)
FI (1) FI961380A (sv)
NO (1) NO961226L (sv)
WO (1) WO1995008998A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132756A (en) * 1996-11-05 2000-10-17 Haque, Inc. Use of sandalwood oil for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
US5945116A (en) * 1996-11-05 1999-08-31 Haque, Inc. Compositions for the prevention and treatment of warts, skin blemishes and other viral-induced tumors
US6406706B1 (en) 1996-11-05 2002-06-18 Haque, Inc. Use of α- and β-santalols major constituents of sandal wood oil, in the treatment of warts, skin blemishes and other viral-induced tumors
US6230013B1 (en) 1997-11-26 2001-05-08 Telefonaktiebolaget Lm Ericsson (Publ) Diversity handling moveover for CDMA mobile telecommunications
CA2276219A1 (en) * 1999-06-25 2000-12-25 Board Of Trustees Of The University Of Arkansas Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US6350451B1 (en) * 1999-06-25 2002-02-26 The Board Of Trustees Of The University Of Arkansas Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US20050175634A1 (en) * 1999-06-25 2005-08-11 The Board Of Trustees Of The University Of Arkansas Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US20070031786A1 (en) * 2002-02-25 2007-02-08 Heil Donald J Dental handpiece
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US7311928B2 (en) * 2003-12-09 2007-12-25 Briant Burke Topical compositions containing tea tree oil for treatment of viral lesions
WO2005121802A1 (de) * 2004-06-09 2005-12-22 Heinz Voigt Proteindifferenzierung
US7998476B2 (en) 2006-11-22 2011-08-16 Standard Biologics, Inc. Method of treatment using Aspergillus oryzae protease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230153A (en) * 1963-06-26 1966-01-18 Birger H Olson Process for the production of regulin by aspergillus restrictus and resulting product
US3819832A (en) * 1970-07-20 1974-06-25 N Joshi Antiviral agent fwh-775 and method of production
JPS5231030B2 (sv) * 1973-05-12 1977-08-12
JPS577420A (en) * 1980-06-18 1982-01-14 Yamasa Shoyu Co Ltd Antitumor agent
JPS5795913A (en) * 1980-12-08 1982-06-15 Yamasa Shoyu Co Ltd Antitumor agent
DE3343331A1 (de) * 1983-11-28 1985-06-05 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von indanyl-derivaten und deren verwendung
BR8902936A (pt) * 1989-05-30 1990-12-04 Nunes E Duran Pesquisa Comerci Anidrido polimerico de fosfolinoleato de magnesio e anonio proteico,com propriedades anti-virais-neoplasticas e imunoestimulantes e processo de obtencao do mesmo
JPH0645547B2 (ja) * 1989-06-05 1994-06-15 雪印乳業株式会社 免疫増強剤
US5316345A (en) * 1992-06-26 1994-05-31 Madison Roberta E Single panel communication card and its color method

Also Published As

Publication number Publication date
NO961226L (no) 1996-05-23
BR9407660A (pt) 1997-01-28
WO1995008998A1 (en) 1995-04-06
AU699133B2 (en) 1998-11-26
US5662902A (en) 1997-09-02
US5562900A (en) 1996-10-08
CA2172261A1 (en) 1995-04-06
US5662903A (en) 1997-09-02
CN1134671A (zh) 1996-10-30
FI961380A0 (sv) 1996-03-26
NO961226D0 (no) 1996-03-26
EP0725646A1 (en) 1996-08-14
JPH09503206A (ja) 1997-03-31
AU7706294A (en) 1995-04-18
CN1087941C (zh) 2002-07-24
KR960704561A (ko) 1996-10-09
US5500359A (en) 1996-03-19

Similar Documents

Publication Publication Date Title
FI971969A0 (sv) Kompositioner för behandling av hemorrojder och användningsmetod
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
FI941826A (sv) Förfaranden och kompositioner för profylaktisk och/eller terapeutisk behandling av ett organs hypofunktion
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BR9106438A (pt) Composicoes terapeuticas sinergisticas e processos
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
BR9403946A (pt) Composição de matéria
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
AU6232794A (en) The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
FI961380A (sv) Kompositioner för hindrande och behandling av tumörer förorsakade av virus
IL114119A0 (en) Compositions and methods for the treatment of tumors
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO932850L (no) Fremgangsmaate for fremstilling av staal
FI931322A0 (fi) Stabilisering av peroxidblekningsvaetskor med klordioxid
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO905310D0 (no) Fremgangsmaate og sammensetning for beskyttelse av metalliske overflater og forbedring av deres loddbarhet.
GB9602444D0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
GB2351904B (en) Herbal composition and use of the composition for treating viral infection of the liver
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
IL111460A0 (en) Composition for the treatment of viral infections
GB9323550D0 (en) Composition for the treatment of hydrothyroidism
KR940002718U (ko) 치질예방 및 치료기